• S&P 500: 1,340.58
  • Change: -0.84%
$3.24 -0.26 (-7.43%)
2/10/2012 2:40 PM

Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Current Price $3.24 Mkt Cap $232.76M
Open $3.45 P/E Ratio 0.00
Prev. Close $3.50 Div. (Yield) N/A (N/A)
Daily Range $3.23 - $3.46 Volume 1,684,160
52-Wk Range $1.70 - $5.30 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think VICL will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

155 Outperform
12 Underperform
 

All-Star Players

33 Outperform
4 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top VICL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.29)
Submitted October 01, 2011

Everyone wants to believe that when the release date for topline data in a phase III cancer trial keeps getting pushed back further and further, it means patients receiving the study drug are living longer. I guess if anyone ever actually finds the… More

1 Comment | Reply | Report this Post

zzlangerhans (99.29)
Submitted July 07, 2011

I won't get too deeply into statistical analysis of Allovectin phase II data and the phase III performance of comparators. The reason for that is people will never see eye to eye regarding the utility of comparing survival in single-arm trials to… More

1 Comment | Reply | Report this Post
VICL VS S&P 500 (SPY)

Fools bullish on VICL are also bullish on:

Fools bearish on VICL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VICL.

Recs

0
Member Avatar irishred1 (62.42) Submitted: 2/9/2012 8:35:49 PM : Underperform Start Price: $3.45 VICL Score: +5.45

I'll go with ZZ on his analysis that Allovectin will fail phase 3... however I like the strong pipeline and after the stock gets cut in half I think it'd be a strong long term buy

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar SarahGen (99.83) Submitted: 12/30/2011 3:07:55 PM : Outperform Start Price: $4.45 VICL Score: -33.26

joseph714 from the Fool biotech board likes this

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar CATMANF800 (< 20) Submitted: 12/3/2011 2:51:12 PM : Outperform Start Price: $4.78 VICL Score: -37.51

Technicals

Report this Post Add Comment | Reply | Permalink
View All 25 Pitches »

Leaderboard

Find the members with the highest scoring picks in VICL.

Score Leader

jgknot

jgknot (99.13) Score: +149.57

The Score Leader is the player with the highest score across all their picks in VICL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
boknows1 < 20 2/18/2011 Outperform 5Y $1.82 +79.12% -0.13% +79.25 0 Comment
thenoob < 20 2/14/2011 Outperform 3Y $1.87 +74.33% +0.55% +73.78 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. chimpcontest < 20 2/22/2011 Outperform 5Y $1.89 +72.49% +0.72% +71.77 11 Comments
xMFJokey < 20 2/8/2011 Outperform 5Y $1.98 +64.65% +1.39% +63.26 0 Comment
rkreddyv < 20 11/17/2010 Outperform 5Y $1.89 +72.49% +13.43% +59.06 0 Comment
johnandmarie123 32.58 1/26/2011 Outperform 5Y $2.03 +60.59% +3.31% +57.28 1 Comment
embodiedheart 84.52 11/11/2010 Outperform 5Y $1.94 +68.04% +10.86% +57.18 0 Comment
cmmtgnmn 69.62 1/20/2011 Outperform 3W $2.04 +59.80% +4.91% +54.89 0 Comment
oncebittenx2shy < 20 1/3/2011 Outperform 5Y $2.03 +60.59% +5.82% +54.77 0 Comment
SaratogaPhil 87.60 11/23/2010 11/29/2011 Outperform 1Y $1.96 +66.33% +12.89% +53.44 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
trackglobalhunte 55.71 12/1/2011 Outperform NS $4.45 -26.74% +7.39% -34.13 0 Comment
TrackJohnRogers 51.10 9/23/2009 Outperform 1Y $4.40 -25.91% +24.93% -50.84 1 Comment
TrackTWeisel 91.96 6/12/2009 Outperform NS $3.05 +6.89% +43.51% -36.63 0 Comment
trackmerriman 71.16 12/20/2006 Outperform NS $6.59 -50.53% +0.04% -50.58 0 Comment

Featured Broker Partners